RxDoctor Payments Data

Jamie Price

Family · Johnstown, PANPI 1639946445

Payments from drug & device makers

$4,337in general payments, 2019–2025

Across 234 payments — averaging $18.53 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.

  • AbbVie$985
  • AstraZeneca$771
  • Lilly USA, LLC$426
  • Pfizer$267
  • Novo Nordisk$237
  • Amgen$211
  • plus $1K from 19 others

What the payments were for

  • Food & beverage$4,337100%

Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.

General payments by program year

24
25

Who reported the general payments

Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.

What the payments were tied to

Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.

How this compares

$4,337 in reported general payments places this provider in the 90th percentile of 4,717 family providers in Pennsylvania.

See all family providers in Pennsylvania

Most prescribed under Part D

DrugClaimsCost to plans & patients
EliquisApixaban27$24,458
JardianceEmpagliflozin17$19,287
OzempicSemaglutide12$14,030
MyrbetriqMirabegron11$9,651
Ventolin HfaAlbuterol Sulfate23$1,243
Gabapentin46$814
Rosuvastatin Calcium35$645
Pantoprazole Sodium61$490
Levothyroxine Sodium28$463
Atorvastatin Calcium46$419
Losartan Potassium22$352
Escitalopram Oxalate31$303
Duloxetine Hcl13$299
Lisinopril35$288
Fluticasone Propionate32$280

Paid to pharmacies, not to this prescriber.

Companies that both paid and supply prescribed drugs

These companies both reported payments to this provider and make drugs the provider prescribed under Medicare Part D in 2024. For most specialties this overlap is expected — a cardiologist who is paid by a cardiology drugmaker also treats heart disease. It is shown so the reader can see it, not because it implies anything on its own.

CompanyPaid to this providerPart D cost of their drugs
PfizerEliquis$267$24,45827 claims
Boehringer IngelheimJardiance$131$19,28717 claims
Novo NordiskOzempic$237$14,03012 claims
Astellas Pharma US IncMyrbetriq$55$9,65111 claims

Reading this fairly. The Part D column is what drug plans and patients paid pharmacies — this provider received none of it, and it reflects how many patients they treat and what those drugs cost. Against peers, this provider's reported payments sit in the 90th percentile of 4,717 family providers in Pennsylvania.

Other family in Johnstown

See the full list for Pennsylvania

Where these figures come from

Is this you, or does something look wrong? →